AU7475896A - Electrochemical oxidation in the production of an epoxide intermediate for synthesizing an hiv protease inhibitor - Google Patents

Electrochemical oxidation in the production of an epoxide intermediate for synthesizing an hiv protease inhibitor

Info

Publication number
AU7475896A
AU7475896A AU74758/96A AU7475896A AU7475896A AU 7475896 A AU7475896 A AU 7475896A AU 74758/96 A AU74758/96 A AU 74758/96A AU 7475896 A AU7475896 A AU 7475896A AU 7475896 A AU7475896 A AU 7475896A
Authority
AU
Australia
Prior art keywords
synthesizing
production
protease inhibitor
hiv protease
electrochemical oxidation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74758/96A
Inventor
Kai Rossen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603756.9A external-priority patent/GB9603756D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7475896A publication Critical patent/AU7475896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU74758/96A 1995-10-30 1996-10-25 Electrochemical oxidation in the production of an epoxide intermediate for synthesizing an hiv protease inhibitor Abandoned AU7475896A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US812595P 1995-10-30 1995-10-30
US008125 1995-10-30
GBGB9603756.9A GB9603756D0 (en) 1996-02-22 1996-02-22 Electrochemical oxidation
GB9603756 1996-02-22
PCT/US1996/017143 WO1997016450A1 (en) 1995-10-30 1996-10-25 Electrochemical oxidation in the production of an epoxide intermediate for synthesizing an hiv protease inhibitor

Publications (1)

Publication Number Publication Date
AU7475896A true AU7475896A (en) 1997-05-22

Family

ID=26308784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74758/96A Abandoned AU7475896A (en) 1995-10-30 1996-10-25 Electrochemical oxidation in the production of an epoxide intermediate for synthesizing an hiv protease inhibitor

Country Status (4)

Country Link
AR (1) AR004071A1 (en)
AU (1) AU7475896A (en)
TW (1) TW415948B (en)
WO (1) WO1997016450A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048595B2 (en) * 1978-10-03 1985-10-28 株式会社クラレ Method for producing halohydrin and/or epoxy
JPS6048982A (en) * 1983-08-29 1985-03-16 Takasago Corp Production of isosafrole halohydrin and/or isosafrole epoxide
TW380137B (en) * 1994-03-04 2000-01-21 Merck & Co Inc Process for making an epoxide

Also Published As

Publication number Publication date
WO1997016450A1 (en) 1997-05-09
AR004071A1 (en) 1998-09-30
TW415948B (en) 2000-12-21

Similar Documents

Publication Publication Date Title
AU7747694A (en) Process for the production of methanol
AU7062496A (en) Process for the production of Bis(silyalkyl)-disulfanes
AU1123595A (en) Method for the oxidation of carbohydrates
AU3562899A (en) Epoxidation process
AU8191898A (en) Process for the electrolytic production of metals
AU3747399A (en) Epoxidation process
AU2676895A (en) Electrochemical oxidation of matter
AU9480998A (en) Process for making manganese
AU1994499A (en) Process for production of hydrogen peroxide
AU4352896A (en) Process for the production of methanol
AU9450098A (en) Production of esters
AU3124495A (en) Method for the production of steel
AU1659395A (en) Production of magnesium metal
AU7174196A (en) Process for the production of ink concentrates
AU3476395A (en) Multihull navigating structure
AU6373698A (en) Production of L(+)-Lactate
AU9512198A (en) Manufacture of thin metal objects
AUPM982594A0 (en) HIV protease inhibitors
AU3188597A (en) Process for the manufacture of lead oxide
AU4267099A (en) Production of polyethylene
GB2298952B (en) Process for the electrochemical oxidation of AM(III) to AM(VI)
AU3472495A (en) Enzymatic, active oxygen-releasing mixture and peracid production
AU6828894A (en) Hiv protease inhibitors
AU8297698A (en) Inhibitors of neutrophil mediated oxidant production
AU5746296A (en) Process for making hiv protease inhibitors